Correction to Lancet Respir Med 2022; 10: 972-84

No authors listed

Published Erratum

No authors listed. Lancet Respir Med. 2022 Dec.

. 2022 Dec;10(12):e116.

doi: 10.1016/S2213-2600(22)00441-6. Epub 2022 Nov 7.

No abstract available

Erratum for

Tixagevimab-cilgavimab for treatment of patients hospitalised with COVID-19: a randomised, double-blind, phase 3 trial.
ACTIV-3–Therapeutics for Inpatients with COVID-19 (TICO) Study Group. ACTIV-3–Therapeutics for Inpatients with COVID-19 (TICO) Study Group. Lancet Respir Med. 2022 Oct;10(10):972-984. doi: 10.1016/S2213-2600(22)00215-6. Epub 2022 Jul 8. Lancet Respir Med. 2022. PMID: 35817072 Free PMC article. Clinical Trial.